Highlights Morepen Laboratories Limited NSE India S.E.

Equities

MOREPENLAB

INE083A01026

Delayed NSE India S.E. Other stock markets 03:47:02 17/05/2024 pm IST			5-day change	1st Jan Change
46.85 ^INR	-1.06%		+1.52%	-3.50%

30/03	Morepen Laboratories Limited Announces Resignation of Lalit Kumar Baregama, Chief Growth Officer	CI
01/03	Morepen Laboratories Limited Announces the Promotion of Amita Sharma to Chief Operating Officer -API	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31/01	CI
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11	CI
Morepen Laboratories to Transfer Formulation Distribution and Marketing Business to Subsidiary	15/23/15	MT
Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	05/23/05	CI
Morepen Laboratories' Net Profit Drops in Fiscal Q4	16/23/16	MT
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	16/23/16	CI
US FDA Clears Morepen Laboratories' Baddi, India	27/23/27	MT
Morepen Laboratories Forms Wholly-Owned Subsidiary	20/23/20	MT
Morepen Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary	17/23/17	CI
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13	CI
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/22/10	CI
Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	29/22/29	CI
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	05/22/05	CI
Morepen Laboratories Sees Drop in Fiscal Q4 Consolidated Net Profit	05/22/05	MT
Morepen Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022	05/22/05	CI
Morepen Laboratories Posts Decline in Fiscal Q3 Consolidated Net Profit	09/22/09	MT
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	08/22/08	CI
Morepen Gets USFDA Approval for Fexofinadine	03/21/03	CI
Morepen Laboratories Clocks 38% Jump in Fiscal Q2 Consolidated Profit	12/21/12	MT
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	11/21/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Morepen Laboratories Limited NSE India S.E.

Equities

MOREPENLAB

INE083A01026

Highlights

Filters